echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > European Radiology: Deep Learning + Radiomics!

    European Radiology: Deep Learning + Radiomics!

    • Last Update: 2022-02-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     Soft tissue sarcoma (STS) originates from mesenchymal tissue, with complex histological components and diverse clinical manifestations, accounting for 1% of the total adult cancer incidence
    .


    At this stage , radical resection is the preferred treatment for STS patients .


     Soft tissue sarcoma (STS) originates from mesenchymal tissue, with complex histological components and diverse clinical manifestations, accounting for 1% of the total adult cancer incidence


    Patients with STSs are often treated with neoadjuvant radiotherapy or chemotherapy after surgical resection to improve the local control rate and prolong their survival time


    The American College of Radiology's appropriateness criteria recommend MRI for monitoring local recurrence of malignant or invasive soft tissue tumors


    Recently, a study published in the journal European Radiology established and tested a model using DL and HCR radiomics signatures to predict the risk of recurrence in patients with STS undergoing surgical resection, while incorporating routinely applied staging systems and other studies.
    Statistical models were incorporated into model comparisons to evaluate the efficacy of this study model in recurrence prediction, and to provide technical support for clinically formulating personalized treatment plans and improving patient prognosis .


    In total , this study evaluated 282 patients undergoing MRI scans and STS surgical resection at three independent centers .
    In addition, 113 of the 282 patients underwent additional contrast- enhancing MRI scans .
    We divided participants into a developmental cohort and an external testing cohort .
    The developmental cohort consisted of patients from one center, and the external testing cohort consisted of patients from two other centers .
    We established two MRI-based DLRNs for predicting tumor recurrence after STS resection .
    We tested DLRNs universally and compared them with other predictive models constructed by using widely adopted predictors (i.
    e.


    The DLRN1 model incorporates plain MRI-based radiomic features into clinical data, and the DLRN2 model combines radiomic features extracted from plain and enhanced MRI with clinical predictors


     

    Fig.
    Prediction of cumulative recurrence rate bydeep learning radiology nomograms (DLRNs) for three different risk stratifications
    .

    Fig.
    Prediction of cumulative recurrence rate bydeep learning radiology nomograms (DLRNs) for three different risk stratifications
    .


    Fig.


    This study constructed two radiomics nomograms based on clinical and radiomic features .


    Original source:

    Shunli Liu,Weikai Sun,Shifeng Yang,et al.


    Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study.


    Shunli Liu,Weikai Sun,Shifeng Yang,et al.
    Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study.
    DOI:10.
    1007/s00330-021-08221-0Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.